High success rate |
Required anesthesia |
Good outcome in small perforations |
Greater surgery time |
Minimally invasive technique |
Open surgical procedure (associated risks) |
Routine clinical practice |
Incision to take the graft and remove squamous epithelium |
Limited availability of autologous graft in revision cases |
Failure of perforation closure due to the deficient regenerative activity at the edges of the injury |
Frequent re-perforation |
Bilaminar neomembrane: flaccid and acoustically suboptimal |
Side effects: retraction pockets, tympanosclerotic mass, rejection |
Tissue engineering |
Surgery simplification |
Mostly animal studies (acute perforations, which would spontaneously close in most cases) |
Cost savings |
Improve outcome in chronic perforations |
Lack of a standard animal model |
Growth factors improve tympanic closure |
Scarce human clinical trials |
Specific design of scaffold materials that reproduce the mechanical properties of the eardrum |
Possible side effects of scaffold materials, biomolecules and cells |
Ethical and legal issues concerning the use of xenografts |
Possibility of generating a commercially available tympanic membrane |
Complex manufacture of the artificial construct (storage, biopreservatives, quality controls, production and transportation costs) |